Patents by Inventor Joseph Perry STEINER

Joseph Perry STEINER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10981977
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or is therapy.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: April 20, 2021
    Assignees: GENEURO SA, THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Hervé Perron, Julie Medina, Avindra Nath, Joseph Perry Steiner, Wenxue Li, Myoung-Hwa Lee
  • Publication number: 20200308258
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or is therapy.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 1, 2020
    Inventors: Hervé PERRON, Julie MEDINA, Avindra NATH, Joseph Perry Steiner, Wenxue LI, Myoung-Hwa LEE
  • Patent number: 10723787
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or in therapy.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: July 28, 2020
    Assignees: GENEURO SA, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Hervé Perron, Julie Medina, Avindra Nath, Joseph Perry Steiner, Wenxue Li, Myound-Hwa Lee
  • Publication number: 20190345232
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or in therapy.
    Type: Application
    Filed: January 19, 2018
    Publication date: November 14, 2019
    Inventors: Hervé PERRON, Julie MEDINA, Avindra NATH, Joseph Perry Steiner, Wenxue LI, Myound-Hwa LEE
  • Publication number: 20190038659
    Abstract: Methods of treating amyotrophic lateral sclerosis (ALS) or preventing the progression of ALS. Compounds useful in these therapeutic methods include anti-retroviral compounds and RNA interference (RNAi) constructs.
    Type: Application
    Filed: September 29, 2016
    Publication date: February 7, 2019
    Inventors: Avindra NATH, Wenxue LI, Joseph Perry STEINER, Myoung Hwa LEE, Lisa HENDERSON, Richa TYAGI